Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)

Yoko Kano, Mikiko Tohyama, Michiko Aihara, Setsuko Matsukura, Hideaki Watanabe, Hirohiko Sueki, Masafumi Iijima, Eishin Morita, Hiroyuki Niihara, Hideo Asada, Kenji Kabashima, Hiroaki Azukizawa, Hideo Hashizume, Keisuke Nagao, Hayato Takahashi, Riichiro Abe, Chie Sotozono, Michiko Kurosawa, Yumi Aoyama, Chia Yu ChuWen Hung Chung, Tetsuo Shiohara

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe adverse drug reaction caused by specific drug. It is characterized by visceral organ involvement and reactivation of various human herpesviruses. Although sporadic reports have documented certain conditions that appear after the resolution of DIHS/DRESS, little information is available on sequelae after resolution of DIHS/DRESS in a large patient population. The Asian Research Committee on Severe Cutaneous Adverse Reactions, comprised of doctors from Japan and Taiwan, conducted a survey on sequelae and deterioration of the underlying disease in patients with DIHS/DRESS. This was achieved by directly interviewing patients who had been followed-up by experts or through a questionnaire mailed to patients. Questions were asked about new onset cardiovascular disease, collagen disease or autoimmune disease, gastrointestinal disease, renal disease, respiratory disease, neoplasms, and other diseases such as herpes zoster and diabetes mellitus, as well as deterioration of the underlying disease. A total of 145 patients were analyzed in this study. The following newly developed diseases after recovery from DIHS/DRESS were observed: Graves' disease (n = 2), Hashimoto's disease (n = 3), painless thyroiditis (n = 2), fulminant type 1 diabetes mellitus (n = 5), and infectious diseases (n = 7). Several DIHS/DRESS patients with pre-existing renal dysfunction required lifelong hemodialysis. DIHS/DRESS is a condition that increases the risk of new onset of disease. Long-term observation of DIHS/DRESS can provide an opportunity to investigate substantial diseases from onset to the full-blown stage. Patients with DIHS/DRESS require careful long-term follow-up.

Original languageEnglish
Pages (from-to)276-282
Number of pages7
JournalJournal of Dermatology
Volume42
Issue number3
DOIs
Publication statusPublished - 2015 Mar 1

Fingerprint

Drug Hypersensitivity Syndrome
Skin
Research
Surveys and Questionnaires

Keywords

  • autoimmune thyroiditis
  • drug reaction with eosinophilia and systemic symptoms
  • drug-induced hypersensitivity syndrome
  • fulminant type 1 diabetes mellitus
  • Graves' disease
  • Hashimoto's disease

ASJC Scopus subject areas

  • Dermatology

Cite this

Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms : Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). / Kano, Yoko; Tohyama, Mikiko; Aihara, Michiko; Matsukura, Setsuko; Watanabe, Hideaki; Sueki, Hirohiko; Iijima, Masafumi; Morita, Eishin; Niihara, Hiroyuki; Asada, Hideo; Kabashima, Kenji; Azukizawa, Hiroaki; Hashizume, Hideo; Nagao, Keisuke; Takahashi, Hayato; Abe, Riichiro; Sotozono, Chie; Kurosawa, Michiko; Aoyama, Yumi; Chu, Chia Yu; Chung, Wen Hung; Shiohara, Tetsuo.

In: Journal of Dermatology, Vol. 42, No. 3, 01.03.2015, p. 276-282.

Research output: Contribution to journalArticle

Kano, Y, Tohyama, M, Aihara, M, Matsukura, S, Watanabe, H, Sueki, H, Iijima, M, Morita, E, Niihara, H, Asada, H, Kabashima, K, Azukizawa, H, Hashizume, H, Nagao, K, Takahashi, H, Abe, R, Sotozono, C, Kurosawa, M, Aoyama, Y, Chu, CY, Chung, WH & Shiohara, T 2015, 'Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)', Journal of Dermatology, vol. 42, no. 3, pp. 276-282. https://doi.org/10.1111/1346-8138.12770
Kano, Yoko ; Tohyama, Mikiko ; Aihara, Michiko ; Matsukura, Setsuko ; Watanabe, Hideaki ; Sueki, Hirohiko ; Iijima, Masafumi ; Morita, Eishin ; Niihara, Hiroyuki ; Asada, Hideo ; Kabashima, Kenji ; Azukizawa, Hiroaki ; Hashizume, Hideo ; Nagao, Keisuke ; Takahashi, Hayato ; Abe, Riichiro ; Sotozono, Chie ; Kurosawa, Michiko ; Aoyama, Yumi ; Chu, Chia Yu ; Chung, Wen Hung ; Shiohara, Tetsuo. / Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms : Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). In: Journal of Dermatology. 2015 ; Vol. 42, No. 3. pp. 276-282.
@article{8855e5e9cb24476787aea95ccc2536d1,
title = "Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)",
abstract = "Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe adverse drug reaction caused by specific drug. It is characterized by visceral organ involvement and reactivation of various human herpesviruses. Although sporadic reports have documented certain conditions that appear after the resolution of DIHS/DRESS, little information is available on sequelae after resolution of DIHS/DRESS in a large patient population. The Asian Research Committee on Severe Cutaneous Adverse Reactions, comprised of doctors from Japan and Taiwan, conducted a survey on sequelae and deterioration of the underlying disease in patients with DIHS/DRESS. This was achieved by directly interviewing patients who had been followed-up by experts or through a questionnaire mailed to patients. Questions were asked about new onset cardiovascular disease, collagen disease or autoimmune disease, gastrointestinal disease, renal disease, respiratory disease, neoplasms, and other diseases such as herpes zoster and diabetes mellitus, as well as deterioration of the underlying disease. A total of 145 patients were analyzed in this study. The following newly developed diseases after recovery from DIHS/DRESS were observed: Graves' disease (n = 2), Hashimoto's disease (n = 3), painless thyroiditis (n = 2), fulminant type 1 diabetes mellitus (n = 5), and infectious diseases (n = 7). Several DIHS/DRESS patients with pre-existing renal dysfunction required lifelong hemodialysis. DIHS/DRESS is a condition that increases the risk of new onset of disease. Long-term observation of DIHS/DRESS can provide an opportunity to investigate substantial diseases from onset to the full-blown stage. Patients with DIHS/DRESS require careful long-term follow-up.",
keywords = "autoimmune thyroiditis, drug reaction with eosinophilia and systemic symptoms, drug-induced hypersensitivity syndrome, fulminant type 1 diabetes mellitus, Graves' disease, Hashimoto's disease",
author = "Yoko Kano and Mikiko Tohyama and Michiko Aihara and Setsuko Matsukura and Hideaki Watanabe and Hirohiko Sueki and Masafumi Iijima and Eishin Morita and Hiroyuki Niihara and Hideo Asada and Kenji Kabashima and Hiroaki Azukizawa and Hideo Hashizume and Keisuke Nagao and Hayato Takahashi and Riichiro Abe and Chie Sotozono and Michiko Kurosawa and Yumi Aoyama and Chu, {Chia Yu} and Chung, {Wen Hung} and Tetsuo Shiohara",
year = "2015",
month = "3",
day = "1",
doi = "10.1111/1346-8138.12770",
language = "English",
volume = "42",
pages = "276--282",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

T2 - Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)

AU - Kano, Yoko

AU - Tohyama, Mikiko

AU - Aihara, Michiko

AU - Matsukura, Setsuko

AU - Watanabe, Hideaki

AU - Sueki, Hirohiko

AU - Iijima, Masafumi

AU - Morita, Eishin

AU - Niihara, Hiroyuki

AU - Asada, Hideo

AU - Kabashima, Kenji

AU - Azukizawa, Hiroaki

AU - Hashizume, Hideo

AU - Nagao, Keisuke

AU - Takahashi, Hayato

AU - Abe, Riichiro

AU - Sotozono, Chie

AU - Kurosawa, Michiko

AU - Aoyama, Yumi

AU - Chu, Chia Yu

AU - Chung, Wen Hung

AU - Shiohara, Tetsuo

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe adverse drug reaction caused by specific drug. It is characterized by visceral organ involvement and reactivation of various human herpesviruses. Although sporadic reports have documented certain conditions that appear after the resolution of DIHS/DRESS, little information is available on sequelae after resolution of DIHS/DRESS in a large patient population. The Asian Research Committee on Severe Cutaneous Adverse Reactions, comprised of doctors from Japan and Taiwan, conducted a survey on sequelae and deterioration of the underlying disease in patients with DIHS/DRESS. This was achieved by directly interviewing patients who had been followed-up by experts or through a questionnaire mailed to patients. Questions were asked about new onset cardiovascular disease, collagen disease or autoimmune disease, gastrointestinal disease, renal disease, respiratory disease, neoplasms, and other diseases such as herpes zoster and diabetes mellitus, as well as deterioration of the underlying disease. A total of 145 patients were analyzed in this study. The following newly developed diseases after recovery from DIHS/DRESS were observed: Graves' disease (n = 2), Hashimoto's disease (n = 3), painless thyroiditis (n = 2), fulminant type 1 diabetes mellitus (n = 5), and infectious diseases (n = 7). Several DIHS/DRESS patients with pre-existing renal dysfunction required lifelong hemodialysis. DIHS/DRESS is a condition that increases the risk of new onset of disease. Long-term observation of DIHS/DRESS can provide an opportunity to investigate substantial diseases from onset to the full-blown stage. Patients with DIHS/DRESS require careful long-term follow-up.

AB - Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe adverse drug reaction caused by specific drug. It is characterized by visceral organ involvement and reactivation of various human herpesviruses. Although sporadic reports have documented certain conditions that appear after the resolution of DIHS/DRESS, little information is available on sequelae after resolution of DIHS/DRESS in a large patient population. The Asian Research Committee on Severe Cutaneous Adverse Reactions, comprised of doctors from Japan and Taiwan, conducted a survey on sequelae and deterioration of the underlying disease in patients with DIHS/DRESS. This was achieved by directly interviewing patients who had been followed-up by experts or through a questionnaire mailed to patients. Questions were asked about new onset cardiovascular disease, collagen disease or autoimmune disease, gastrointestinal disease, renal disease, respiratory disease, neoplasms, and other diseases such as herpes zoster and diabetes mellitus, as well as deterioration of the underlying disease. A total of 145 patients were analyzed in this study. The following newly developed diseases after recovery from DIHS/DRESS were observed: Graves' disease (n = 2), Hashimoto's disease (n = 3), painless thyroiditis (n = 2), fulminant type 1 diabetes mellitus (n = 5), and infectious diseases (n = 7). Several DIHS/DRESS patients with pre-existing renal dysfunction required lifelong hemodialysis. DIHS/DRESS is a condition that increases the risk of new onset of disease. Long-term observation of DIHS/DRESS can provide an opportunity to investigate substantial diseases from onset to the full-blown stage. Patients with DIHS/DRESS require careful long-term follow-up.

KW - autoimmune thyroiditis

KW - drug reaction with eosinophilia and systemic symptoms

KW - drug-induced hypersensitivity syndrome

KW - fulminant type 1 diabetes mellitus

KW - Graves' disease

KW - Hashimoto's disease

UR - http://www.scopus.com/inward/record.url?scp=84924140432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924140432&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.12770

DO - 10.1111/1346-8138.12770

M3 - Article

C2 - 25623158

AN - SCOPUS:84924140432

VL - 42

SP - 276

EP - 282

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 3

ER -